Analogous to the in vitro results (Fig. 7a,b), retinal detachment-induced caspase 8 activation was inhibited by ML-265 treatment in a dose-dependent manner as compared to DMSO treated eyes (Fig. 8c). The gene discussed is CASP8; the disease is retinal detachment.